Cole Schotz Formalizes Multidisciplinary Life Sciences Practice Group

Cole Schotz is excited to announce the formal launch of its Life Sciences Industry Group to further build on the firm’s experience of successfully servicing life sciences clients on high-stakes legal matters.

The group brings together a cross-disciplinary team advising clients ranging from multi-national entities to emerging companies across the medical device, biotech, pharmaceutical, investment and healthcare fields. Cole Schotz has significant experience handling a wide range of transactional, due diligence and litigation matters to provide boutique attention alongside high-end legal counsel.

“Our firm has a long track record of successfully advising life sciences clients on their legal needs so that they can focus on developing products and other innovations that save, elongate and change lives,” said firm member William Stroever, co-founder of the Life Sciences Group. “I’m excited to see what we’ll be able to accomplish during this next phase of growth.”

“Our life sciences clients operate in a dynamic and innovative sector that requires a deep understanding of the industry’s landscape in order to succeed,” added member Kumar Vinnakota, who also serves as co-founder of the group. “Our team is comprised of attorneys from across the firm to help these companies every step of the way.”

The Life Sciences Group advises on matters ranging from licensing deals and contentious intellectual property disputes to complex mergers and acquisitions, commercial contracts, real estate transactions and financings. The team’s services also include compliance counseling and workplace training regarding employment law issues, as well as employment litigation defense and commercial disputes and litigation, including alternative dispute resolution.